marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2022-Q1
hinzugefügt 29.06.2022
Takeda Pharmaceutical Company Limited Kennzahlen 2011-2024 | TAK
Kennzahlen Jährlich Takeda Pharmaceutical Company Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
0.1 | 138.7 | 35.2 | 19.3 | 36.8 | 51.2 | -30.3 | 36.1 | 35.8 | 30.2 | 16.9 |
P/S |
0.0 | 1.9 | 1.8 | 2.0 | 2.4 | 2.3 | 2.5 | 2.3 | 3.0 | 2.5 | 2.9 |
EPS |
240.7 | 28.4 | 140.6 | 239.3 | 147.2 | - | - | - | - | - | - |
EV (Enterprise Value) |
6.79 T | 7.51 T | 8.04 T | 1.83 T | 2.13 T | 1.85 T | 2.13 T | 2.06 T | 1.78 T | 1.54 T | 688 B |
EBITDA per Share |
326 | 230 | 186 | 233 | 200 | 163 | 30 | 179 | 205 | 263 | 300 |
EV/EBITDA |
13.3 | 6.3 | 14.2 | 2.0 | 2.8 | 1.4 | 2.5 | 0.8 | 0.9 | 0.3 | -0.4 |
PEG |
0.0 | -1.85 | -0.67 | 0.31 | 0.84 | -0.33 | 0.13 | -1.93 | 6.29 | -0.6 | -1.01 |
P/B |
0.0 | 1.3 | 0.7 | 1.8 | 2.2 | 2.1 | 2.1 | 1.6 | 2.2 | 1.9 | 2.0 |
P/CF |
0.0 | - | 0.2 | 0.1 | 0.3 | -0.6 | 0.5 | 0.5 | 0.2 | 0.1 | 0.2 |
ROE % |
7.27 | 0.94 | 2.12 | 9.36 | 6.07 | 4.11 | -6.82 | 4.32 | 6.08 | 6.17 | 11.85 |
ROA % |
2.91 | 0.35 | 0.79 | 4.55 | 2.64 | 2.10 | -3.39 | 2.33 | 3.32 | 3.47 | 8.90 |
ROCE % |
4.57 | 2.50 | 1.36 | 7.18 | 5.21 | 4.41 | -3.94 | 3.70 | 3.67 | 9.38 | 15.62 |
Current Ratio |
1.7 | 1.1 | 1.2 | 1.5 | 0.9 | 1.6 | 1.5 | 2.0 | 2.4 | 1.7 | 3.6 |
DSO |
- | 79.3 | 130.4 | 88.4 | 93.7 | 87.0 | 95.8 | 95.5 | - | - | - |
DIO |
- | 254.4 | 546.0 | 156.7 | 147.8 | 173.2 | 183.8 | 189.3 | 187.2 | 164.3 | 157.6 |
DPO |
- | 70.9 | 117.5 | 176.8 | 157.2 | 130.3 | 119.6 | 137.7 | 96.8 | 83.0 | 242.9 |
Betriebszyklus |
- | 333.7 | 676.3 | 245.1 | 241.6 | 260.1 | 279.6 | 284.9 | 187.2 | 164.3 | 157.6 |
Finanzkreislauf |
- | 262.8 | 558.8 | 68.3 | 84.4 | 129.8 | 160.0 | 147.2 | 90.4 | 81.4 | -85.3 |
Alle Zahlen in JPY-Währung
Kennzahlen Vierteljährlich Takeda Pharmaceutical Company Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 1.8 | - | - | - | 1.7 | - | - | - | 1.6 | - | - | - | 1.6 | - | - | - | 2.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in JPY-Währung